Tripos (TRPS) Announces Advancement To Pre-Clinical Development In Drug Discovery Collaboration With Chronogen Inc.
6/28/2006 5:00:38 PM
More...
|
Chronogen Inc. Receives Approval To Proceed With A Phase I/II Clinical Trial
4/26/2006 10:18:16 AM
More...
|
Chronogen Inc. Secures (US) $3.275M Of Financing From MMV Financial Inc.
3/28/2006 11:08:28 AM
More...
|
Chronogen Inc. Strengthens R & D With A New Management Position
1/9/2006 12:43:47 PM
More...
|
Chronogen Inc. Demonstrates That Mammalian Aging Is Under The Control Of CLK-1 Activity
10/26/2005 11:51:26 AM
More...
|
Chronogen Inc. Announces Two Senior Appointments
10/19/2005 5:13:15 PM
More...
|
Chronogen Inc. Announces A Partnership With Sosei Co., Ltd. For The Screening Of The Sosei Drug Reprofiling Platform(R) Compound Library
10/19/2005 5:12:12 PM
More...
|
Chronogen Inc. Names Dr. Max Fehlmann, Ph.D. MBA, New President And CEO
10/19/2005 5:12:03 PM
More...
|
Chronogen Inc. Appoints New Scientific Advisory Board
10/19/2005 5:11:39 PM
More...
|
Chronogen Inc. Names Mr. Kees Been, Chief Executive Officer Of Bionaut Pharmaceuticals, Inc. To Board Of Directors
10/19/2005 5:10:57 PM
More...
|
|